Oral penicillins. Pharmacodynamic and pharmacokinetic properties
Adam, D.; Heinzl, S.
Medizinische Monatsschrift für Pharmazeuten 12(4): 117-122
1989
ISSN/ISBN: 0342-9601 PMID: 2657357 Document Number: 327775
Document emailed within 1 workday
Related Documents
Bergogne-Bérézin, E. 1997: Fluoroquinolones. Pharmacokinetic properties and new pharmacodynamic concepts Presse Medicale 26(12): 577-582Muir, W.W.; Sams, R.A.; Huffman, R.H.; Noonan, J.S. 1982: Pharmacodynamic and pharmacokinetic properties of diazepam in horses American Journal of Veterinary Research 43(10): 1756-1762
Weidinger, G. 1995: Pharmacokinetic and pharmacodynamic properties and therapeutic use of bunazosin in hypertension. A review Arzneimittel-Forschung 45(11): 1166-1171
Palmer, G.C.; Murray, R.J.; Cramer, C.L.; Stagnitto, M.L.; Knowles, M.K.; Freedman, L.R.; Eismann, M.S.; Mahmood, N.; Balestra, M.; Borrelli, A.R.; Hudzik, T.J.; McCarthy, D.J. 1999: S]-AR-R 15896AR-A novel anticonvulsant: acute safety, pharmacokinetic and pharmacodynamic properties Journal of Pharmacology and Experimental Therapeutics 288(1): 121-132
Brogden, R.N.; Buckley, M.M.; Ward, A. 1990: Buserelin. a review of its pharmacodynamic and pharmacokinetic properties, and clinical profile Drugs 39(3): 399-437
Orzechowska-Juzwenko, K. 1998: Optimizing pharmacotherapeutic aspects of pharmacokinetic and pharmacodynamic drug properties in the elderly Przeglad Lekarski 55(11): 607-610
Breithaupt-Grögler, K.; Malerczyk, C.; Belz, G.G.; Butzer, R.; Herrmann, V.; Stass, H.; Wensing, G. 1997: Pharmacodynamic and pharmacokinetic properties of an angiotensin Ii receptor antagonist--characterization by use of Schild regression technique in man International Journal of Clinical Pharmacology and Therapeutics 35(10): 434-441
Tittle, V.; Bull, L.; Boffito, M.; Nwokolo, N. 2015: Pharmacokinetic and pharmacodynamic drug interactions between antiretrovirals and oral contraceptives Clinical Pharmacokinetics 54(1): 23-34
Tittle, V.; Bull, L.; Boffito, M.; Nwokolo, N. 2015: Pharmacokinetic and pharmacodynamic drug interactions between antiretrovirals and oral contraceptives Clinical Pharmacokinetics 54(1): 23-34
Tittle, V.; Bull, L.; Boffito, M.; Nwokolo, N. 2015: Pharmacokinetic and pharmacodynamic drug interactions between antiretrovirals and oral contraceptives Clinical Pharmacokinetics 54(1): 23-34
Langnickel, R.; Bluth, R. 1985: Pharmacokinetic properties and indications for modern vasodilators. 1. Pharmacodynamic properties of vasodilators Zeitschrift für Arztliche Fortbildung 79(19): 821-825
Põder, P.; Eha, J.; Sundberg, S.; Antila, S.; Heinpalu, M.; Loogna, I.; Planken, U.; Rantanen, S.; Lehtonen, L. 2003: Pharmacokinetic-pharmacodynamic interrelationships of intravenous and oral levosimendan in patients with severe congestive heart failure International Journal of Clinical Pharmacology and Therapeutics 41(8): 365-373
Cawello, W.; Rosenkranz, B.; Schmid, B.; Wierich, W. 2013: Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers Epilepsia 54(3): 530-536
Lin, W.H.; Feng, H.-P.; Shadle, C.R.; O'Reilly, T.; Wagner, J.A.; Butterton, J.R. 2014: Pharmacokinetic and pharmacodynamic interactions between the hepatitis C virus protease inhibitor, boceprevir, and the oral contraceptive ethinyl estradiol/norethindrone European Journal of Clinical Pharmacology 70(9): 1107-1113
Tromm, A.; Griga, T.; May, B. 1999: Oral mesalazine for the treatment of Crohn's disease: clinical efficacy with respect to pharmacokinetic properties Hepato-Gastroenterology 46(30): 3124-3135
Diefenbach, C.; Künzer, T.; Buzello, W.; Theisohn, M. 1995: Alcuronium: a pharmacodynamic and pharmacokinetic update Anesthesia and Analgesia 80(2): 373-377
Covino, B.G. 1984: Pharmacodynamic and pharmacokinetic aspects of local anesthetics Annales Chirurgiae et Gynaecologiae 73(3): 118-122
Welker, H.A.; Banken, L. 1998: Mibefradil pharmacokinetic and pharmacodynamic population analysis International Journal of Clinical Pharmacology Research 18(2): 63-71
Wu, W.H.; Henderson, B.M.; Lanc, R.; Garnes, D.; Yacobi, A.; Silber, B.M. 1988: Relationship between the pharmacokinetic and pharmacodynamic profile of nilvadipine in the dog Drug Metabolism and Disposition: the Biological Fate of Chemicals 16(2): 222-227
Chen, J.K.; Song, S.; Yang, P.J.; He, M.L.; Fan, S.B.; Li, L.M.; Gui, Y.L.; Fotherby, K. 1990: A pharmacodynamic and pharmacokinetic study of the Chinese No. 1 pill Contraception 42(4): 439-453